The Overview: December 2020
We’re probably all ready to say goodbye to 2020, if we have to be honest with ourselves. And yet, we can’t look back and say that the year was entirely bad. With your … Continued
News
OCRA Research Investigates Role of Extracellular Vesicles in Cancer Research
OCRA-funded researchers Dr. Sunila Pradeep and Dr. Pradeep Chaluvally-Raghavan, both at the Medical College of Wisconsin, along with colleagues, summarized recent literature on the function of extracellular vesicles “in regulating … Continued
Applying Computational Biology to Ovarian Cancer | Meet a Scientist
Could the next ovarian cancer breakthrough be traced back to a Commodore 64 home computer? After all, in some small measure, OCRA grantee Dr. Sohrab Shah is where he is … Continued
OCRA-Funded Scientists Further Study Gene Mutation Connected to Ovarian Cancer
An international collaborative of scientists, including Dr. Ronald Chandler at Michigan State University, studied ARID1A mutations, which are specific gene mutations observed in deep ovarian and deep infiltrating endometriosis. The … Continued
The Overview: November 2020
We’re full on into fall, and giving thanks for all that we’ve accomplished together, in a year that’s been more than a little challenging. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS EVENTS WAYS … Continued
Give the gift that keeps on giving … in more ways than one
We’ve got the perfect gift for everyone on your holiday list, and you never have to step foot in a store. With a suggested donation of $25 or more, you … Continued
Now Accepting Applications for 2021 Advocate Leader Program
Be a voice for the ovarian cancer community. Please note: The deadline for application was December 7, 2020. Sign up for email alerts to stay updated on opportunities to take … Continued
Watch Expert Presentations from OCRA’s 2020 Virtual National Conference
Want to learn what’s new in ovarian cancer research and care for 2020? Start here. This fall, we hosted our virtual Uniting for Hope Ovarian Cancer National Conference, where experts … Continued
OCRA’s Statement on SCOTUS and the Affordable Care Act (ACA)
The Supreme Court is poised to consider California v. Texas, which will decide the fate of the Affordable Care Act (ACA) — their decision could threaten health coverage for millions … Continued
Focusing on the Next Line of Defense Against Ovarian Cancer | Meet a Scientist
There is an 80% recurrence rate when it comes to ovarian cancer, so the question of ‘what next?’ takes on a huge importance. This is the question that Sarah Gitto, … Continued
OCRA Hosts Listening Session With FDA About COVID-19
OCRA Hosts Listening Session With FDA About COVID-19
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation. Watch the full FDA … Continued
The Overview: October 2020
It’s been an incredibly busy end of summer/beginning of fall here at OCRA with a double header of Ovarian Cancer Awareness Month and our Uniting for Hope Ovarian Cancer National Conference. We’ve … Continued